Gino Kang

US Patent:

20110265825, Nov 3, 2011

Filed:

May 2, 2011

Appl. No.:

13/099324

Inventors:

Bobby E. Rogers - San Diego CA, US
Gino Kang - Irvine CA, US

Assignee:

Ivera Medical Corporation - San Diego CA

International Classification:

B08B 9/00
A61L 2/18
A61L 2/16

US Classification:

134 221, 134166 R

Abstract:

A cleaning device for a site of a medical implement is disclosed, as are methods for using such devices. The cleaning device can include a cap having an opening to an inner cavity, and the opening can be adapted to receive a site of the medical implement. The inner cavity can include a male luer protrusion that extends up from an inner wall toward the opening, and can be sized and adapted for insertion into a female luer when the cap is provided on the medical implement. The cleaning device can further include a cleaning material that contains a cleaning agent prior to receipt of the site of the medical implement, i.e. the cleaning material is pre-loaded with the cleaning agent. The cleaning material can be at least partially secured in the inner cavity and adapted to swab and clean the site with the cleaning agent. The cap can further include a friction-forming member for creating a friction-based fitting of the cap onto the site of the medical implement.

US Patent:

20120216359, Aug 30, 2012

Filed:

Feb 16, 2012

Appl. No.:

13/398736

Inventors:

Bobby E. Rogers - San Diego CA, US
Gino Kang - Irvine CA, US

Assignee:

Ivera Medical Corporation - San Diego CA

International Classification:

B08B 1/00

US Classification:

1510493

Abstract:

A cleaning system for medical implements includes a number of cleaning caps attached to a substrate. Each cleaning cap can be selectively and individually removed from the substrate, which, prior to such removal, acts as a seal to the opening of each cap. Each cap includes an inner cavity accessible through the opening. The inner cavity holds a cleaning material that contains a cleaning agent, which is held in the inner cavity by the seal provided by the substrate. Upon removal, the cap can be placed on a site of a medical implement to clean the site by contact with the cleaning material and cleaning agent.

US Patent:

20230116910, Apr 13, 2023

Filed:

Apr 26, 2022

Appl. No.:

17/730118

Inventors:

- San Diego CA, US
Gino KANG - Irvine CA, US
David Karl STROUP - San Diego CA, US
Jonas Dean COCHRAN - Santee CA, US
Arthur DEPTALA - Santee CA, US
John DETLOFF - San Diego CA, US
Lonnie POGUE - San Diego CA, US
Brian MACOWSKI - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153
A61B 5/154

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20210145336, May 20, 2021

Filed:

Nov 10, 2020

Appl. No.:

17/094692

Inventors:

- San Diego CA, US
Gino KANG - Irvine CA, US
David Karl STROUP - San Diego CA, US
Jonas Dean COCHRAN - Santee CA, US
Arthur DEPTALA - Santee CA, US
John DETLOFF - San Diego CA, US
Lonnie POGUE - San Diego CA, US
Brian MACOWSKI - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20190159711, May 30, 2019

Filed:

Dec 4, 2018

Appl. No.:

16/208559

Inventors:

- San Diego CA, US
Gino Kang - Irvine CA, US
John Detloff - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153
A61M 39/04
A61M 39/06
A61B 5/154

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20180289304, Oct 11, 2018

Filed:

May 31, 2018

Appl. No.:

15/994559

Inventors:

- San Diego CA, US
Gino Kang - Irvine CA, US
John Detloff - San Diego CA, US

Assignee:

KURIN, INC. - San Diego CA

International Classification:

A61B 5/15
A61B 5/153
A61M 39/06
A61M 39/04
A61B 5/154
A61M 39/02

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20170143447, May 25, 2017

Filed:

Feb 8, 2017

Appl. No.:

15/427520

Inventors:

- SAINT PAUL MN, US
GINO KANG - IRVINE CA, US

Assignee:

3M INNOVATIVE PROPERTIES COMPANY - SAINT PAUL MN

International Classification:

A61B 90/70
B08B 1/00
B08B 3/08
A61M 39/20
A61M 39/16

Abstract:

A cleaning device for a medical implement such as a female Luer connector. The cleaning device includes a cap having an interior cavity and an opening adapted to receive a site of the medical implement. The interior cavity is defined by an interior wall that includes a male Luer protrusion extending in the direction of the opening from an end of the interior cavity opposite the opening. A skin of cleaning material overlies at least a portion of the interior wall. The cleaning material may be pre-loaded with a cleaning agent and is adapted to clean the site of the medical implement.

US Patent:

20170020427, Jan 26, 2017

Filed:

Apr 27, 2016

Appl. No.:

15/140443

Inventors:

- San Diego CA, US
Gino Kang - Irvine CA, US
John Detloff - San Diego CA, US

International Classification:

A61B 5/15
A61M 39/04

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.